Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland

References

• Ozdoganoglu T, Songu M, Inancli HM. Quality of life in allergic rhinitis. Ther Adv Respir Dis 2012;6:25-39
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Berto P, Ariano R, et al. Cost-effectiveness of allergen immunotherapy. Allergy Ther 2012;S7:6
   Google Scholar
• Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol 2015;136:556-68
   PubMed Web of Science ®Google Scholar
• Cox L. Allergy immunotherapy in reducing healthcare cost. Curr Opin Otolaryngol Head Neck Surg 2015;23:247-54
   PubMed Web of Science ®Google Scholar
• Martinez-Moragon E, Serra-Batlles J, De Diego A, et al. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study]. Arch Bronconeumol 2009;45:481-6
   PubMed Web of Science ®Google Scholar
• Reinhold T, Brüggenjürgen B. Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment. Allergo J Int 2017;26:7-15
   PubMedGoogle Scholar
• Barton P, Bryan S, Robinson S. Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy 2004;9:110-8
   PubMedGoogle Scholar
• Icks A, Chernyak N, Bestehorn K, et al. [Methods of health economic evaluation for health services research]. Gesundheitswesen 2010;72:917-33
   PubMed Web of Science ®Google Scholar
• Pfaar O, Bachert C, Bufe A, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int 2014;23:282-319
   PubMedGoogle Scholar
• Westerhout KY, Verheggen BG, Schreder CH, et al. Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany. J Med Econ 2012;15:906-17
   PubMedGoogle Scholar
• Verheggen BG, Westerhout KY, Schreder CH, et al. Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany. Clin Transl Allergy 2015;5:1
   PubMed Web of Science ®Google Scholar
• Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-6
   PubMed Web of Science ®Google Scholar
• Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851-7
   PubMed Web of Science ®Google Scholar
• Senna G, Lombardi C, Canonica GW, et al. How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers’ viewpoint. J Allergy Clin Immunol 2010;126:668-9
   PubMed Web of Science ®Google Scholar
• Sieber J, De Geest S, Shah-Hosseini K, et al. Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates. Curr Med Res Opin 2011;27:855-61
   PubMed Web of Science ®Google Scholar
• Kiel MA, Roder E, Gerth van Wijk R, et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol 2013;132:353-60 e2
   PubMed Web of Science ®Google Scholar
• Andreasen JN, Lawton S, Boberg Baech S. Compliance and persistence to grass immunotherapy treatment is comparable for allergy immunotherapy tablets and subcutaneous immunotherapy: a Swedish registry study. World Allergy Org J 2012;5(Supplement2):1
   Google Scholar
• Allergiezentrum_Schweiz. Pollendaten – Saisonverlauf; Bern: Allergiezentrum Schweiz; 2017. https://www.pollenundallergie.ch/infos-zu-pollen-und-allergien/polleninformationen/pollendaten/
   Google Scholar
• Subiza J. Calendario de polinización. Madrid: Stallergenes Greer; 2017. http://encuentralainspiracion.es/la-alergia-respiratoria/tipos-de-alergenos/alergia-al-polen/calendario-de-polinizacion/
   Google Scholar
• Medizinische_Universität_Wien. Pollen-Jahr Wien: Medizinische Universität Wien; 2017. https://www.pollenwarndienst.at/aktuelle-belastung/pollen-jahr.html
   Google Scholar
• Allergopharma. Gebrauchsinformation und Fachinformation für Präparate der ALLERGOVIT®-Reihe. Reinbek: Allergopharma; 2017
   Google Scholar
• Allergopharma. Summary of Product Characteristics -Allergovit® Pollen preparations (Spain). Madrid: Allergopharma; 2016
   Google Scholar
• Stallergenes. Product Monograph - Full prescribing information; Cambridge (MA): 2017. http://www.oralair.com/hcp/materials/ORALAIR_Product_Monograph.pdf
   Google Scholar
• Piñana VdL, Martínez PG, Aguilar CM. Manejo Práctico de Inmunoterapia. In: editors. Inmunoterapia con alérgenos en el tratamiento de las enfermedades alérgicas. Barcelona: CdIS; 2010. p. 23-30
   Google Scholar
• Corrigan CJ, Kettner J, Doemer C, et al. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005;60:801-7
   PubMed Web of Science ®Google Scholar
• Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-45
   PubMed Web of Science ®Google Scholar
• Didier A, Worm M, Horak F, et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 2011;128:559-66
   PubMed Web of Science ®Google Scholar
• Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123:160-6 e3
   PubMed Web of Science ®Google Scholar
• Cox L, Wallace D. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual. Immunol Allergy Clin North Am 2011;31:561-99
   PubMed Web of Science ®Google Scholar
• Revicki DA, Leidy NK, Brennan-Diemer F, et al. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998;7:693-702
   PubMed Web of Science ®Google Scholar
• Bernert S, Fernandez A, Haro JM, et al. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value Health 2009;12:750-8
   PubMed Web of Science ®Google Scholar
• Brüggenjürgen B, Reinhold T, Brehler R, et al. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma. Ann Allergy Asthma Immunol 2008;101:316-24
   PubMed Web of Science ®Google Scholar
• Kaplan RM. The minimally clinically important difference in generic utility-based measures. COPD 2005;2:91-7
   PubMedGoogle Scholar
• Cox L. The role of allergen immunotherapy in the management of allergic rhinitis. Am J Rhinol Allergy 2016;30:48-53
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Mauro M, Leo G, et al. Adherence to sublingual immunotherapy. Curr Allergy Asthma Rep 2016;16:12
   PubMed Web of Science ®Google Scholar
• Senna G, Ridolo E, Calderon M, et al. Evidence of adherence to allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol 2009;9:544-8
   PubMed Web of Science ®Google Scholar
• Egert-Schmidt AM, Kolbe JM, Mussler S, et al. Patients’ compliance with different administration routes for allergen immunotherapy in Germany. Patient Prefer Adherence 2014;8:1475-81
   PubMed Web of Science ®Google Scholar
• Lemberg ML, Berk T, Shah-Hosseini K, et al. Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center. Patient Prefer Adherence 2017;11:63-70
   PubMed Web of Science ®Google Scholar
• Dretzke J, Meadows A, Novielli N, et al. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol 2013;131:1361-6
   PubMed Web of Science ®Google Scholar
• Nelson HS. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? J Allergy Clin Immunol Pract 2014;2:144-9; quiz 150–1
   PubMed Web of Science ®Google Scholar
• Di Bona D, Plaia A, Leto-Barone MS, et al. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. J Allergy Clin Immunol 2012;130:1097-107 e2
   PubMed Web of Science ®Google Scholar
• Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010;125:131-8 e1–7
   PubMed Web of Science ®Google Scholar
• Eng PA, Borer-Reinhold M, Heijnen IA, et al. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006;61:198-201
   PubMed Web of Science ®Google Scholar
• Schmitt J, Schwarz K, Stadler E, et al. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study. J Allergy Clin Immunol 2015;136:1511-16
   PubMed Web of Science ®Google Scholar
• Zielen S, Devillier P, Heinrich J, et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis. Allergy 2017;73:165-177
   PubMed Web of Science ®Google Scholar
• Robaina JC, Sanchez CP, Perez EE. Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain. ClinicoEconom Outcomes Res 2016;8:6
   Web of Science ®Google Scholar
• WHO. Mortality rates 25–34 years based on “Total deaths all causes (male + female + unknown sex)” and “Population - numbers”. Kopenhagen: WHO; 2017 http://apps.who.int/healthinfo/statistics/mortality/whodpms/params_ex.php
   Google Scholar
• Botplus Buscar Nombre: Consejo General De Colegios Oficiales de Farmaceúticos. Madrid: Consejo General De Colegios Oficiales de Farmaceuticos 2017. https://botplusweb.portalfarma.com/
   Google Scholar
• Arzneimittel-Kompendium. Bern: HCI Solutions; 2017. http://compendium.ch
   Google Scholar
• Arzneimittelsuche - Produktdetails: Uniapotheke.at. 2017 http://www.uniapotheke.at/
   Google Scholar
• Consejería de Sanidad. Resolución de 25 de febrero de 2014, de la Directora, por la que se modifica la cuantía de los precios públicos de servicios sanitarios previstos en el Decreto 81/2009, de 16 de junio, que establece los precios públicos de los servicios sanitarios prestados por el Servicio Canario de la Salud y fija sus cuantías. Las Palmas de Gran Canaria: Gobierno de Canarias; 2014. Boletín Oficial de Canarias núm. 61, de 27 de marzo de 2014
   Google Scholar
• Servicio Murciano de Salud. Precios públicos pruebas realizadas en el Servicio Murciano de Salud. Murcia: Servicio Murciano de Salud; 2015. BORM 10-febrero-2015
   Google Scholar
• Ärztekammer Kärnten. Honorarordnung. Klagenfurt: Ärztekammer Kärnten und Hauptverband der österreichischen Sozialversicherungsträger; 2012
   Google Scholar
• Anonymous-Sozialversicherungsträger. Ärzte-Gesamtvertrag (kompilierte Fassung). Wien: Hauptverband der österreichischen Sozialversicherungsträger; 2014
   Google Scholar
• Anonymous-TARMED. Leistungen. Bern: TARMED; 2017. http://www.tarmed-browser.ch
   Google Scholar
• Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009;9:24
   PubMedGoogle Scholar
• Jacob C, Bechtel B, Engel S, et al. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis. Eur J Health Econ 2016;17:195-201
   PubMed Web of Science ®Google Scholar